Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
990.2 INR | -0.73% | +5.53% | +30.40% |
Sales 2024 * | 63.38B 761M | Sales 2025 * | 70.38B 845M | Capitalization | 196B 2.35B |
---|---|---|---|---|---|
Net income 2024 * | 5.92B 71.04M | Net income 2025 * | 7.03B 84.39M | EV / Sales 2024 * | 3.13 x |
Net Debt 2024 * | 2.62B 31.42M | Net cash position 2025 * | 457M 5.49M | EV / Sales 2025 * | 2.78 x |
P/E ratio 2024 * |
33
x | P/E ratio 2025 * |
27.8
x | Employees | 14,593 |
Yield 2024 * |
0.89% | Yield 2025 * |
1.01% | Free-Float | 29.28% |
Latest transcript on Alembic Pharmaceuticals Limited
1 day | -0.75% | ||
1 week | +5.50% | ||
Current month | +0.53% | ||
1 month | +2.33% | ||
3 months | +7.48% | ||
6 months | +32.57% | ||
Current year | +30.37% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Manisha Saraf
CMP | Compliance Officer | - | 23-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 83-04-30 | |
Director of Finance/CFO | 64 | 03-01-17 | |
Director/Board Member | 56 | 15-02-03 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.00% | 117 M€ | +0.16% | - | |
0.00% | 34 M€ | +2.22% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 990.2 | -0.73% | 274 350 |
24-04-25 | 997.5 | +4.12% | 136,404 |
24-04-24 | 958 | +1.89% | 60,861 |
24-04-23 | 940.2 | -1.24% | 57,145 |
24-04-22 | 952.1 | +1.47% | 61,662 |
Delayed Quote NSE India S.E., April 26, 2024 at 05:36 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.37% | 2.35B | |
+24.94% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.32% | 233B | |
+5.64% | 201B | |
-10.14% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- APLLTD Stock